When MT was expressed in human breast cancer cells we found that the interferon response depended on the presence of RNaseL and interferon regulatory factor 7 (IRF7), the key effector molecules at the proximal and distal ends of the OAS-RNaseL signaling pathway [16]. The gene discussed is RNASEL; the disease is breast cancer.